AADI
Price:
$3
Market Cap:
$73.94M
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.[Read more]
Industry
Biotechnology
IPO Date
2018-02-16
Stock Exchange
NASDAQ
Ticker
AADI
According to Aadi Bioscience, Inc.’s latest financial reports and current stock price. The company's current ROE is -71.87%. This represents a change of 297.03% compared to the average of -18.10% of the last 4 quarters.
The mean historical ROE of Aadi Bioscience, Inc. over the last ten years is -63.47%. The current -71.87% ROE has changed 13.25% with respect to the historical average. Over the past ten years (40 quarters), AADI's ROE was at its highest in in the March 2016 quarter at 2.18%. The ROE was at its lowest in in the March 2018 quarter at -66.83%.
Average
-63.47%
Median
-49.26%
Minimum
-434.06%
Maximum
136.30%
Discovering the peaks and valleys of Aadi Bioscience, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 259.41%
Maximum Annual ROE = 136.30%
Minimum Annual Increase = -2444.78%
Minimum Annual ROE = -434.06%
Year | ROE | Change |
---|---|---|
2023 | -62.52% | 73.68% |
2022 | -36.00% | -55.40% |
2021 | -80.71% | -388.49% |
2020 | 27.98% | -143.92% |
2019 | -63.69% | 259.41% |
2018 | -17.72% | -85.56% |
2017 | -122.74% | -190.06% |
2016 | 136.30% | -131.40% |
2015 | -434.06% | -2444.78% |
2014 | 18.51% | -15.95% |
The current ROE of Aadi Bioscience, Inc. (AADI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-59.74%
5-year avg
-42.99%
10-year avg
-63.47%
Aadi Bioscience, Inc.’s ROE is greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Adagene Inc. (-50.10%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than AnaptysBio, Inc. (-287.94%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Gracell Biotechnologies Inc. (-15.56%), greater than Theseus Pharmaceuticals, Inc. (-12.35%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Design Therapeutics, Inc. (-18.01%), greater than Erasca, Inc. (-42.26%), greater than Rezolute, Inc. (-69.83%), greater than Ultragenyx Pharmaceutical Inc. (-187.12%), greater than Crinetics Pharmaceuticals, Inc. (-36.12%), greater than Arvinas, Inc. (-50.26%), greater than Revolution Medicines, Inc. (-33.67%), greater than Kura Oncology, Inc. (-44.09%),
Company | ROE | Market cap |
---|---|---|
-184.40% | $39.16M | |
-50.10% | $88.76M | |
-47.95% | $191.80M | |
-287.94% | $426.46M | |
-55.92% | $618.62M | |
-57.63% | $40.49M | |
-90.19% | $74.87M | |
-15.56% | $989.87M | |
-12.35% | $181.50M | |
-62.68% | $433.74M | |
-18.01% | $353.88M | |
-42.26% | $730.85M | |
-69.83% | $255.24M | |
-187.12% | $4.01B | |
-36.12% | $4.96B | |
-50.26% | $1.27B | |
-33.67% | $8.04B | |
-44.09% | $688.21M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aadi Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aadi Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Aadi Bioscience, Inc.'s ROE?
How is the ROE calculated for Aadi Bioscience, Inc. (AADI)?
What is the highest ROE for Aadi Bioscience, Inc. (AADI)?
What is the 3-year average ROE for Aadi Bioscience, Inc. (AADI)?
What is the 5-year average ROE for Aadi Bioscience, Inc. (AADI)?
How does the current ROE for Aadi Bioscience, Inc. (AADI) compare to its historical average?